ETR:DRW3 Drägerwerk AG & Co. KGaA (DRW3) Stock Price, News & Analysis €86.20 +5.10 (+6.29%) As of 05/18/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesBuy This Stock About Drägerwerk AG & Co. KGaA Stock (ETR:DRW3) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get DRW3 alerts:Sign Up Key Stats Today's Range€81.10▼€86.3050-Day Range€81.10▼€99.4052-Week Range€43.20▼€56.20Volume42,575 shsAverage Volume33,804 shsMarket Capitalization€1.50 billionP/E Ratio14.26Dividend Yield2.63%Price TargetN/AConsensus RatingN/A Company Overview Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, equipment, and services for acute point of care, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas detection technology, and integrated hazard management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products portfolio includes anesthesia devices and ventilators, thermoregulation equipment, hospitable consumables and accessories, supply units, lights, gas management systems, patient monitoring, software applications, system products, and other services. The company's product portfolio also comprises stationary and mobile gas detection systems, personal protective equipment, and alcohol and drug testing devices. In addition, it offers various training and services, as well as fire training facilities for firefighters. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh. Read More Receive DRW3 Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Drägerwerk AG & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DRW3 Stock News HeadlinesEQS-News: Drägerwerk AG & Co. KGaA: Keine Abstimmung zu den Punkten 7 und 8 der Tagesordnung in der ordentlichen Hauptversammlung am 8. Mai 2026 - Absage der gesonderten ...May 8, 2026 | finanznachrichten.deEQS-News: Drägerwerk AG & Co. KGaA: Dräger mit starkem ersten Quartal 2026April 30, 2026 | finanznachrichten.deSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.May 19 at 1:00 AM | Brownstone Research (Ad)EQS-Adhoc: Drägerwerk AG & Co. KGaA: Vorläufige Zahlen Q1 2026: Ergebnis deutlich über VorjahrApril 18, 2026 | finanznachrichten.deDraegerwerk AG & Co. KGaA: Fokus auf Rentabilität mit klar definiertem Margenverlauf; KAUFEN.April 15, 2026 | finanznachrichten.deDRAEGERWERK AG & CO KGAAMarch 31, 2026 | finanznachrichten.deDraegerwerk AG & Co. KGaA: Die Ergebnisse für das Geschäftsjahr 2025 bestätigen die Ertragskraft; Kursziel und Bewertung angehoben; KAUFEN.March 24, 2026 | finanznachrichten.deDrägerwerk AG & Co. KGaA reports FY results; gives FY26 outlookMarch 24, 2026 | seekingalpha.comSee More Headlines DRW3 Stock Analysis - Frequently Asked Questions How have DRW3 shares performed this year? Drägerwerk AG & Co. KGaA's stock was trading at €69.40 on January 1st, 2026. Since then, DRW3 stock has increased by 24.2% and is now trading at €86.20. What other stocks do shareholders of Drägerwerk AG & Co. KGaA own? Based on aggregate information from My MarketBeat watchlists, some other companies that Drägerwerk AG & Co. KGaA investors own include Meta Platforms (META), ServiceNow (NOW), NVIDIA (NVDA), Broadcom (AVGO), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD) and Salesforce (CRM). Industry, Sector and Symbol Stock ExchangeETR SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolETR:DRW3 CIKN/A Webwww.draeger.com Phone+49-451-8820FaxN/AEmployees16,476Year FoundedN/AProfitability EPS (Trailing Twelve Months)€6.04 Trailing P/E Ratio14.26 Forward P/E Ratio19.37 P/E Growth1.24Net Income€103.84 million Net Margins4.36% Pretax MarginN/A Return on Equity9.79% Return on Assets3.63% Debt Debt-to-Equity Ratio13.64 Current Ratio2.07 Quick Ratio0.81 Sales & Book Value Annual Sales€3.56 billion Price / Sales0.42 Cash Flow€24.04 per share Price / Cash Flow3.59 Book Value€88.29 per share Price / Book0.98Miscellaneous Outstanding Shares17,430,281Free FloatN/AMarket Cap€1.50 billion OptionableNot Optionable Beta0.69 Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report This page (ETR:DRW3) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drägerwerk AG & Co. KGaA Please log in to your account or sign up in order to add this asset to your watchlist. Share Drägerwerk AG & Co. KGaA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
